
We know exercise is good for you. Why? He‘s working on it.
The Gerszten Lab is a national leader in metabolomics and proteomics technologies. Among its key discoveries, the lab has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from early clinical interventions.
The Gerszten Lab is taking a close look at molecular signs of disease with the goal of uncovering early risk factors and identifying high-risk individuals appropriate for preventive interventions.